In summary, the present findings suggest that expression of the hepatic htr2b is increased in young diabetic db/db mice and KKAy mice, and pharmacologic inhibition of htr2b ameliorates the hyperglycemia and altered expression of hepatic FGF21, Sdf2l1 and htr2a in these mice. This evidence concerns the gene FGF21 and Hyperglycemia.